lymfotoxin-alfa1, beta2-heterotrimer [Lymphotoxin alpha1, beta2 Heterotrimer]

tematický
Termíny

lymfotoxin-alfa1beta2
lymfotoxin-alfabeta

 

Lymphotoxin alpha1beta2
Lymphotoxin alphabeta
Lymphotoxin alphabeta Heterotrimer

Perzistentní odkaz   https://www.medvik.cz/link/D053361
Definice

A heterotrimer complex consisting of one molecule of LYMPHOTOXIN-ALPHA and two molecules of the LYMPHOTOXIN-BETA. It is anchored to the cell surface via the transmembrane domains of the lymphotoxin-beta component and has specificity for the LYMPHOTOXIN BETA RECEPTOR. The lymphotoxin alpha1, beta2 heterotrimer plays a role in regulating lymphoid ORGANOGENESIS and the differentiation of certain subsets of NATURAL KILLER CELLS.

DUI
D053361 MeSH Prohlížeč
CUI
M0492829
Předchozí užití
Tumor Necrosis Factors (1974-2006)
Historická pozn.
2007
Veřejná pozn.
2007

D Chemikálie a léčiva
D12.644 peptidy 1 380
D12.644.276.374 cytokiny 2 153
D12.644.276.374.750 tumor nekrotizující faktory 371
D12.644.276.374.750.030 antigeny CD70
D12.644.276.374.750.061 faktor aktivující B-buňky 37
D12.644.276.374.750.065 ligand 4-1BB 1
D12.644.276.374.750.092 ligand CD30 2
D12.644.276.374.750.124 ligand CD40 23
D12.644.276.374.750.155 cytokin TWEAK 2
D12.644.276.374.750.186 ektodysplasiny 4
D12.644.276.374.750.249 ligand Fas 18
D12.644.276.374.750.500 lymfotoxin-alfa 17
D12.644.276.374.750.515 lymfotoxin-beta
D12.644.276.374.750.531 ligand OX40 1
D12.644.276.374.750.562 ligand RANK 142
D12.644.276.374.750.625 protein TRAIL 38
D12.644.276.374.750.626 TNF-alfa 1 305
D12.644.276.374.750.656 protein TALL-2 2
D12.644.276.374.750.690 protein TNFSF14
D12.644.276.374.750.720 ligand TL1
D12.776 proteiny 2 575
D12.776.467.374 cytokiny 2 153
D12.776.467.374.750 tumor nekrotizující faktory 371
D12.776.467.374.750.030 antigeny CD70
D12.776.467.374.750.061 faktor aktivující B-buňky 37
D12.776.467.374.750.065 ligand 4-1BB 1
D12.776.467.374.750.092 ligand CD30 2
D12.776.467.374.750.124 ligand CD40 23
D12.776.467.374.750.155 cytokin TWEAK 2
D12.776.467.374.750.186 ektodysplasiny 4
D12.776.467.374.750.249 ligand Fas 18
D12.776.467.374.750.500 lymfotoxin-alfa 17
D12.776.467.374.750.515 lymfotoxin-beta
D12.776.467.374.750.531 ligand OX40 1
D12.776.467.374.750.562 ligand RANK 142
D12.776.467.374.750.625 protein TRAIL 38
D12.776.467.374.750.626 TNF-alfa 1 305
D12.776.467.374.750.656 protein TALL-2 2
D12.776.467.374.750.690 protein TNFSF14
D12.776.467.374.750.710 ligand TL1
D23.529.374 cytokiny 2 153
D23.529.374.750.030 antigeny CD70
D23.529.374.750.061 faktor aktivující B-buňky 37
D23.529.374.750.065 ligand 4-1BB 1
D23.529.374.750.092 ligand CD30 2
D23.529.374.750.124 ligand CD40 23
D23.529.374.750.155 cytokin TWEAK 2
D23.529.374.750.186 ektodysplasiny 4
D23.529.374.750.249 ligand Fas 18
D23.529.374.750.500 lymfotoxin-alfa 17
D23.529.374.750.515 lymfotoxin-beta
D23.529.374.750.531 ligand OX40 1
D23.529.374.750.562 ligand RANK 142
D23.529.374.750.625 protein TRAIL 38
D23.529.374.750.626 TNF-alfa 1 305
D23.529.374.750.656 protein TALL-2 2
D23.529.374.750.690 protein TNFSF14
D23.529.374.750.710 ligand TL1